Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01109992 · ClinicalTrials.gov registry record · Phase 4
Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 43
- Enrollment target
NCT01109992 is a Phase 4 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 43 participants.
The verdict
NCT01109992, a Phase 4 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 43 participants
- Enrollment target
Study Summary
This is a single-center study of subjects undergoing clinically indicated heart scans for evaluation of known or suspected heart disease. We will also include 10 healthy subjects without known heart disease. We would like to study stress testing of the heart using exercise and a medication called regadenoson. Imaging of the heart will be performed.
Interventions
- DRUG Exercise plus Regadenoson (Lexercise)
- DRUG Regadenoson (Lexiscan)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-02 |
| Est. Completion | 2017-06-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01109992
The ClinicalTrials.gov registry entry for NCT01109992 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exercise plus Regadenoson (Lexercise) is the first listed.
NCT01109992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01109992 about?
NCT01109992 is a clinical study titled "Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET". This is a single-center study of subjects undergoing clinically indicated heart scans for evaluation of known or suspected heart disease. We will also include 10 healthy subjects without known heart disease. We would like to study stress testing of the heart using exercise and a medication called re...
What is the current status of trial NCT01109992?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 43 participants. The study started on 2011-02. Estimated completion is 2017-06-06.
What interventions are being tested in trial NCT01109992?
The interventions under investigation include: Exercise plus Regadenoson (Lexercise) (DRUG), Regadenoson (Lexiscan) (DRUG).
Who is sponsoring clinical trial NCT01109992?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.